% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • boxcarlong boxcarlong Dec 12, 2011 12:38 PM Flag

    FXIRx and APOIIIRx

    positive P1 Data on Two potential Blockbuster Antisense ISIS drugs.

    Pipeline results/Platform results (2.2 & 2.5) on these early stage blockbusters bodes well for the technology. 2012 going to look even better.

    When Antisense gets Hot .... OGXI gets Hotter
    as an investment


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ISIS hitting on all cylinders in regards to knocking down targets and in the lab. The new computers that ISIS in regards to what they are looking for have dramatically improved their chances for success. They entered into an agreement with ALNY for ssRNAi technology that ALNY pulled out of as they could not figure out how to make ssRNAi work.....ISIS did and they did such a good job that ssRNAi drugs are almost as potent as 2.0 generation drugs, and could compete for a place on ISIS pipeline depending on the illness and need. ISIS has also found a way to make their 2.0 generation drugs between 3 and 5 times stronger than previously. The leader in ANS, genetic splicing, ssRNAi technology, mRNA with Regulus, the sky is the limit once wall street realizes what this miniature giant has to offer. I'm especially excited about their Factor XI drug and their ApoC III drug. Nothing like this company IMO. t

0.46-0.09(-16.38%)Oct 27 3:59 PMEDT